(Q37055211)

18 August 2017

1 reference

title

Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer (English)

1 reference

Stenotrophomonas maltophilia

18 August 2017

0 references

1 reference

Amar Safdar

1

1 reference

18 August 2017

Kenneth V Rolston

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

Clinical Infectious Diseases

18 August 2017

published in

1 reference

18 August 2017

volume

45

1 reference

18 August 2017

issue

12

1 reference

18 August 2017

page(s)

1602-1609

1 reference

Infectious morbidity in critically ill patients with cancer

18 August 2017

cites work

1 reference

Changing trends in etiology of bacteremia in patients with cancer.

21 January 2018

1 reference

The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients

21 January 2018

1 reference

Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones

21 January 2018

1 reference

Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003).

21 January 2018

1 reference

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

21 January 2018

1 reference

Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients

21 January 2018

1 reference

The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen

21 January 2018

1 reference

Stenotrophomonas maltophilia: an unusual cause of biliary sepsis

21 January 2018

1 reference

Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhea

21 January 2018

1 reference

Survey of antibiotic susceptibility among gram-negative bacilli at a cancer hospital.

21 January 2018

1 reference

Implantable venous port-related infections in cancer patients.

21 January 2018

1 reference

Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse

21 January 2018

1 reference

Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis

21 January 2018

1 reference

Stenotrophomonas maltophilia: an increasing problem in patients with acute leukaemia.

21 January 2018

1 reference

Stenotrophomonas maltophilia meningitis. Report of two cases and review of the literature

21 January 2018

1 reference

Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases

21 January 2018

1 reference

Stenotrophomonas maltophilia endocarditis

21 January 2018

1 reference

The clinical spectrum of stenotrophomonas (xanthomonas) maltophilia respiratory infection

21 January 2018

1 reference

Lethal pulmonary hemorrhage caused by a fulminant Stenotrophomonas maltophilia respiratory infection in an acute myeloid leukemia patient

21 January 2018

1 reference

Management of overactive bladder and urge urinary incontinence in the elderly patient

21 January 2018

1 reference

Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.

21 January 2018

1 reference

Stenotrophomonas maltophilia bacteremia in burn patients

21 January 2018

1 reference

In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents

21 January 2018

1 reference

A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy

21 January 2018

1 reference

Antimicrobial therapy for Stenotrophomonas maltophilia infections

21 January 2018

1 reference

Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates

21 January 2018

1 reference

Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.

21 January 2018

1 reference

In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations

21 January 2018

1 reference

Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.

21 January 2018

1 reference

Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia

21 January 2018

1 reference

Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro

21 January 2018

1 reference

Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia

21 January 2018

1 reference

Tigecycline: a new glycylcycline for treatment of serious infections

21 January 2018

1 reference

In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia

21 January 2018

1 reference

In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies

21 January 2018

1 reference

Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia

21 January 2018

1 reference

Resistance patterns among nosocomial pathogens: trends over the past few years

21 January 2018

1 reference

In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa

21 January 2018

1 reference

In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa

21 January 2018

1 reference

In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii

21 January 2018

1 reference

In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.

21 January 2018

1 reference

Beta-lactamase inhibitors: evolving compounds for evolving resistance targets

21 January 2018

1 reference

Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepacia

21 January 2018

1 reference

In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains

21 January 2018

1 reference

Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/522998

1 reference

18 August 2017

1 reference